Olema Pharmaceuticals OLMA 深 沪
已收盘 12-12 16:00:00 美东时间
33.05
+1.470
+4.65%
华盛通- 最 高33.4395
- 今 开32.14
- 成交量 368.46万股
- 最 低 31.32
- 昨 收 31.58
- 总市值 22.68亿
- 52周最高 33.4982
- 市盈率 静 --
- 换手率 5.37%
- 52周最低 2.86
- 委 比 20.16%
- 总股本 6863.43万
- 历史最高 60.27
- 量 比 1.02
- 振 幅 6.71%
- 历史最低 2.00
- 每 手 1
- 风险率 5.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
12-12 10:24
Goldman Sachs Maintains Buy on Olema Pharmaceuticals, Raises Price Target to $38
Goldman Sachs analyst Richard Law maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and raises the price target from $26 to $38.
12-12 01:27
Daktronics, Photronics, Dave & Buster's Entertainment, GE Vernova And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Nasdaq Composite falling more than 100 points ...
12-10 23:41
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing targeted therapies for breast cancer, has granted stock options to two new employees for a total of 65,000 shares, effective December 1, 2025. The stock options vest over four years and have an exercise price of $27.95 per share, aligned with Nasdaq’s inducement rules. These awards were approved under the Company's 2022 Inducement Plan. Olema is advancin...
12-02 21:30
美股大行评级 | 最高130美元！11家大行集体上调沃尔玛目标价；戴康工业、Gap、罗斯百货等均或多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Fractyl Health"买入"评级，目标价从6美元升至8美元；HC Wainwright & Co.：维持MediWound"买入"评级，目标价从31美元升至36美元
11-24 11:23
美股周涨跌榜 | 社交电商平台WeShop上市一周涨超275%；精密科学周涨超50%，获雅培230亿美元收购
社交电商平台WeShop上市一周涨超275%；精密科学周涨超50%，获雅培230亿美元收购；SEMrush周涨近67%，获Adobe收购>>
11-22 10:30
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference
Olema Pharmaceuticals, a clinical-stage biopharmaceutical company focused on targeted therapies for breast cancer, announced its participation in a fireside chat at the 8th Annual Evercore Healthcare Conference on December 3, 2025. Live webcasts and recordings will be available on its investor relations website. The company is advancing therapies, including palazestrant (OP-1250) and OP-3136, for endocrine-driven cancers. Headquartered in San Fra...
11-21 21:30
美股盘前 | 锂矿概念股再度走强，SGML盘前飙升16%；普拉格能源盘前重挫超17%
锂矿概念股再度走强，SGML盘前飙升16%，美国雅保盘前涨超1%；普拉格能源盘前重挫超17%，公司宣布发行3.75亿美元可转换债券>>
11-19 17:23
美股牛股 | 嘉楠科技飙升20%，Q3挖矿收入激增241%；Diginex涨超19%，公司与EVIDENT达成战略合作
嘉楠科技飙升20%，Q3营收破1.5亿美元，挖矿收入激增241%；Diginex涨超19%，公司与EVIDENT达成战略合作>>
11-19 16:54
